Dr. Hofstein currently serves as president and CEO of MaRS Innovation.
As former CEO of Hadasit Ltd., the Technology Holdings Company of Hadassah Medical Organization, he was responsible for management and strategic planning of daughter companies and the commercialization of intellectual property.
Prior to that position, Dr. Hofstein served as the President of Mindsense Biosystems Ltd. where he was responsible for the business development and overall company communications with the investment community as well as budget planning. He also served as Business Unit Director of Ecogen Inc. in Langhorne PA after serving as the Scientific Director of its Israel office.
Dr. Hofstein received his PhD and Master of Science in life-sciences and chemistry from the Weizmann Institute of Science, and his Bachelor of Science in chemistry and physics from the Hebrew University in Jerusalem. Dr. Hofstein completed postdoctoral training at the Harvard Medical School in Boston, MA, in both the departments of biological chemistry and neurobiology.
